Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (AnPAF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01527279
Recruitment Status : Completed
First Posted : February 7, 2012
Last Update Posted : May 22, 2015
Information provided by (Responsible Party):
Institute of Cardiology, Warsaw, Poland